Background: For various reasons, kidney transplant recipients with autosomal dominant polycystic kidney disease (ADPKD) often undergo native nephrectomy in preparation for the transplantation. Simultaneous nephrectomy can result in hypotensive events perioperatively and affect transplant outcome adversely. Our aim was to evaluate the effect of simultaneous native nephrectomy (SNx) on perioperative blood pressure and graft outcome compared to non-nephrectomy (NNx) in renal transplant recipients with ADPKD.
INTRODUCTION
Autosomal dominant polycystic kidney disease (ADPKD)
is the most common genetic cause of chronic kidney disease (1) . About 50% of patients in their 60s progress to end-stage renal failure, requiring renal replacement therapy, and ADPKD is a causal disease in ∼2% of incident cases of end-stage renal disease in Korea (2) . It causes kidney enlargement and deformation, leading to destruction of the renal parenchyma, and thus, a decline in kidney function.
Kidney transplantation is recognized as the optimal measure by replacing the malfunctioning kidneys.
The indications for and timing of nephrectomy in ADPKD patients remain controversial for those undergoing kidney transplantation (3) (4) (5) (6) (7) (8) (9) (10) (11) . Today, there is a general con- (12) . However, the removal of polycystic kidneys at the time of renal grafting is still controversial.
In some ADPKD patients, the size of the kidneys and associated symptoms provide sufficient indication for simultaneous native nephrectomy (SNx). However, there are concerns regarding perioperative complications associated with native nephrectomy, including hypotensive events (13, 14) .
While we have experienced a few cases of poor graft outcome in nephrectomy patients who had severe hypotensive events during the perioperative period, few studies have addressed the association between SNx and hypotensive events and graft outcome in kidney transplantation in ADPKD patients.
Thus, the purpose of this study was to determine the effect of SNx on hypotensive events and graft outcome in ADPKD patients who underwent kidney transplantation.
The primary outcome was graft function after kidney transplantation, with or without simultaneous nephrectomy, and the secondary outcomes were patient and graft survival, postoperative hypotensive events, and blood pressure control.
MATERIALS AND METHODS
The local ethics committee approved this study. We retrospectively reviewed the records of the 52 patients with ADPKD who underwent kidney transplantation at Seoul National University Hospital from 1999 to 2012. Ten patients were excluded from the analysis due to nephrectomy prior to kidney transplantation (n=8), inadequate data (n=1), and loss to follow-up (n=1). After transplantation, the patients had regular outpatient visits at the transplantation center. Serum creatinine was measured by the isotope dilution mass spectrometry traceable method, and estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration formula. Preoperative blood pressure was measured at the medical office prior to kidney transplantation. Postoperative blood pressure was recorded in an inpatient setting within the first week, after which it was measured during follow up in the medical office for 1 year, beginning 1 month after kidney transplantation. Hypotensive event was defined as a drop in systolic blood pressure greater than 40 mmHg or the need for volume resuscitation or inotropics to maintain adequate blood pressure. We reviewed the patients' clinical records for the following parameters: age at transplantation, gender, height, and weight at transplantation, date of transplantation, presence of hypertension, preoperative and postoperative blood pressure, units of antihypertensive medication, graft source, cold ischemic times, immunosuppressive therapy, time and cause of graft loss, and patient death. We calculated units of antihypertensive medication using the lowest dose in a tablet as one unit. For example, 10 mg of amlodipine corresponds to two units, as 5 mg of amlodipine is the lowest dose in a tablet. al rates were 100% vs. 94.4% (P=0.456) ( Fig. 1A ) and the graft survival rates were 100% vs. 90.5% (P=0.273) in the NNx and SNx groups, respectively (Fig. 1B) .
Statistical analysis

Perioperative blood pressure and its effect on graft outcome
There were more hypotensive events in the SNx group (n=18, 69.2%) than in the NNx group (n=6, 37.5%, P=0.045). We explored the effects of native nephrectomy on blood pressure and graft outcome in terms of hypotensive events. All of the subjects in the SNx group were subdivided into two groups according to hypotensive events.
There were no significant differences in demographic or transplant-related characteristics between the two groups ( There was no difference in systolic blood pressure between the NNx and SNX groups during the 1-year follow-up ( Fig. 2A) . We examined the number of units of antihypertensive medication needed due to nephrectomy. In this study, SNx did not result in the adverse effects on graft outcome or patient survival that were reported in previous studies (5, 6, 8) . However, hypotensive events during the immediate postoperative period occurred more often with native nephrectomy. Hypertension develops early in the life of ADPKD patients. Increased activity of the renin-angiotensin system (RAS) associated with extracellular volume expansion might play an important role in the development of hypertension in these patients (16, 17) . It has been suggested that cyst expansion, leading to focal areas of renal ischemia and enhanced renin release, is responsible for high blood pressure. Thus, native nephrectomy might 
DISCUSSION
CONCLUSION
In conclusion, SNx is a relatively safe procedure, and in this study, graft outcome in patients who underwent SNx was not inferior to that of patients who did not undergo SNx. Although SNx could have a potential risk of hypotensive events, with the support of careful monitoring and intervention, it had no harmful influence on outcome.
However, this study had several limitations. The small sample size probably limited statistical power to report a significant difference, and the reason the hypotensive events group had good renal function was not fully investigated.
Prospective studies to measure renin-angiotensin level and evaluate cardiac function will be needed in the future.
